199 related articles for article (PubMed ID: 3003193)
1. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
Lee JC; Rebar L; Young P; Ruscetti FW; Hanna N; Poste G
J Immunol; 1986 Feb; 136(4):1322-8. PubMed ID: 3003193
[TBL] [Abstract][Full Text] [Related]
2. Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.
Kleinerman ES; Zicht R; Sarin PS; Gallo RC; Fidler IJ
Cancer Res; 1984 Oct; 44(10):4470-5. PubMed ID: 6088039
[TBL] [Abstract][Full Text] [Related]
3. Constitutive production of a non-interferon macrophage activating factor by HTLV-transformed T cells.
Lee JC
Lymphokine Res; 1986; 5 Suppl 1():S127-32. PubMed ID: 3023762
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
[TBL] [Abstract][Full Text] [Related]
5. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
[TBL] [Abstract][Full Text] [Related]
6. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
[TBL] [Abstract][Full Text] [Related]
7. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
Hamann U; Krammer PH
Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.
Schreiber RD; Hicks LJ; Celada A; Buchmeier NA; Gray PW
J Immunol; 1985 Mar; 134(3):1609-18. PubMed ID: 2578513
[TBL] [Abstract][Full Text] [Related]
9. Constitutive production of novel macrophage-activating factor(s) by human T cell hybridomas.
Taniyama T; Taki S; Akiyama Y; Yoshizawa K; Hamuro J; Arai K; Wong GG
Clin Invest Med; 1990 Dec; 13(6):305-12. PubMed ID: 2127737
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon.
Schreiber RD; Pace JL; Russell SW; Altman A; Katz DH
J Immunol; 1983 Aug; 131(2):826-32. PubMed ID: 6408190
[TBL] [Abstract][Full Text] [Related]
11. Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma.
Margolick JB; Ambrus JL; Volkman DJ; Fauci AS
J Immunol; 1986 Jan; 136(2):546-54. PubMed ID: 2416812
[TBL] [Abstract][Full Text] [Related]
12. Identity between human interferon-gamma and "macrophage-activating factor" produced by human T lymphocytes.
Talmadge KW; Gallati H; Sinigaglia F; Walz A; Garotta G
Eur J Immunol; 1986 Dec; 16(12):1471-7. PubMed ID: 3102242
[TBL] [Abstract][Full Text] [Related]
13. Lymphokine stimulation of human macrophage C2 production is partially due to interferon-gamma.
Sanders KM; Littman BH
J Immunol; 1986 Aug; 137(3):876-9. PubMed ID: 3088114
[TBL] [Abstract][Full Text] [Related]
14. A lymphokine distinct from interferon-gamma that activates human monocytes to kill Leishmania donovani in vitro.
Hoover DL; Finbloom DS; Crawford RM; Nacy CA; Gilbreath M; Meltzer MS
J Immunol; 1986 Feb; 136(4):1329-33. PubMed ID: 3080522
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
Biondi A; Roach JA; Schlossman SF; Todd RF
J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929
[TBL] [Abstract][Full Text] [Related]
16. Characterization of hydrogen peroxide-potentiating factor, a lymphokine that increases the capacity of human monocytes and monocyte-like cell lines to produce hydrogen peroxide.
Gately CL; Wahl SM; Oppenheim JJ
J Immunol; 1983 Dec; 131(6):2853-8. PubMed ID: 6438232
[TBL] [Abstract][Full Text] [Related]
17. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.
Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP
J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463
[TBL] [Abstract][Full Text] [Related]
18. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
Meltzer MS; Benjamin WR; Farrar JJ
J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 1 (IL 1)-dependent lymphokine production by human leukemic T cell line HSB.2 subclones.
Kasahara T; Mukaida N; Hatake K; Motoyoshi K; Kawai T; Shiori-Nakano K
J Immunol; 1985 Mar; 134(3):1682-9. PubMed ID: 3871456
[TBL] [Abstract][Full Text] [Related]
20. Lymphokine-mediated induction of cytolytic activity in a T cell hybridoma.
Kanagawa O; Chiller JM
J Immunol; 1985 Jan; 134(1):397-403. PubMed ID: 3917280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
